Ilaria Laurenzana
Overview
Explore the profile of Ilaria Laurenzana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
833
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzoccoli C, Crispo F, Laurenzana I, Pietrafesa M, Sisinni L, Lerose R, et al.
Arch Pharm (Weinheim)
. 2023 Aug;
356(10):e2300354.
PMID: 37603378
Targeting tubulin polymerization and depolymerization represents a promising approach to treat solid tumors. In this study, we investigated the molecular mechanisms underlying the anticancer effects of a structurally novel tubulin...
2.
Laurenzana I, De Luca L, Zoppoli P, Calice G, Sgambato A, Carella A, et al.
Clin Exp Med
. 2023 Apr;
23(8):4493-4510.
PMID: 37029309
Allogeneic hematopoietic stem cell transplantation (AHSCT) is a life-saving treatment for selected hematological malignancies. So far, it remains unclear whether transplanted hematopoietic stem/progenitor cells (HSPCs) undergo epigenetic changes upon engraftment...
3.
Trino S, Laurenzana I, Lamorte D, Calice G, De Stradis A, Santodirocco M, et al.
Front Oncol
. 2022 Apr;
12:824562.
PMID: 35371979
Acute myeloid leukemia (AML) is an aggressive and heterogeneous clonal disorder of hematopoietic stem/progenitor cells (HSPCs). It is not well known how leukemia cells alter hematopoiesis promoting tumor growth and...
4.
Sala G, Pacelli C, Agriesti F, Laurenzana I, Tucci F, Tamma M, et al.
Biomedicines
. 2022 Jan;
10(1).
PMID: 35052705
Defining the metabolic phenotypes of cancer-initiating cells or cancer stem cells and of their differentiated counterparts might provide fundamental knowledge for improving or developing more effective therapies. In this context...
5.
Laurenzana I, Trino S, Lamorte D, De Stradis A, Santodirocco M, Sgambato A, et al.
Front Med (Lausanne)
. 2022 Jan;
8:793040.
PMID: 34977093
Multiple myeloma (MM) is characterized by the abnormal proliferation of clonal plasma cells (PCs) in bone marrow (BM). MM-PCs progressively occupy and likely alter BM niches where reside hematopoietic stem...
6.
Rinaldi R, Miglionico R, Nigro I, DOrsi R, Chiummiento L, Funicello M, et al.
Cells
. 2021 Nov;
10(11).
PMID: 34831275
Several pre-clinical and clinical reports suggest that HIV-1 protease inhibitors, in addition to the antiretroviral properties, possess pleiotropic pharmacological effects including anticancer action. Therefore, we investigated the pro-apoptotic activity in...
7.
Lucchetti D, Zurlo I, Colella F, Ricciardi-Tenore C, Di Salvatore M, Tortora G, et al.
Sci Rep
. 2021 Nov;
11(1):22686.
PMID: 34811396
Liquid biopsy has become a useful alternative in metastatic colorectal cancer (mCRC) patients when tissue biopsy of metastatic sites is not feasible. In this study we aimed to investigate the...
8.
Laurenzana I, Trino S, Lamorte D, Girasole M, Dinarelli S, De Stradis A, et al.
Int J Nanomedicine
. 2021 May;
16:3141-3160.
PMID: 33994784
Introduction: Extracellular vesicles (EVs) are naturally secreted cellular lipid bilayer particles, which carry a selected molecular content. Owing to their systemic availability and their role in tumor pathogenesis, circulating EVs...
9.
Horchani M, Sala G, Caso A, DAria F, Esposito G, Laurenzana I, et al.
Int J Mol Sci
. 2021 Apr;
22(5).
PMID: 33800505
Chemotherapy represents the most applied approach to cancer treatment. Owing to the frequent onset of chemoresistance and tumor relapses, there is an urgent need to discover novel and more effective...
10.
Trino S, Lamorte D, Caivano A, De Luca L, Sgambato A, Laurenzana I
Leukemia
. 2020 Dec;
35(3):661-678.
PMID: 33299143
In the era of precision medicine, liquid biopsy is becoming increasingly important in oncology. It consists in the isolation and analysis of tumor-derived biomarkers, including extracellular vesicles (EVs), in body...